3-(benzenesulfonamido)-4-[4-(4-chlorophenyl)piperazin-1-yl]benzoic acid;2,2,2-trifluoroacetic acid
C25H23ClF3N3O6S — CID 146054057
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-(benzenesulfonamido)-4-[4-(4-chlorophenyl)piperazin-1-yl]benzoic acid;2,2,2-trifluoroacetic acid
3-(benzenesulfonamido)-4-[4-(4-chlorophenyl)piperazin-1-yl]benzoic acid;2,2,2-trifluoroacetic acid (PubChem CID 146054057) has the molecular formula C25H23ClF3N3O6S and a molecular weight of 585.99 g/mol. Its IUPAC name is 3-(benzenesulfonamido)-4-[4-(4-chlorophenyl)piperazin-1-yl]benzoic acid;2,2,2-trifluoroacetic acid.
Molecular Properties
| Compound Name | 3-(benzenesulfonamido)-4-[4-(4-chlorophenyl)piperazin-1-yl]benzoic acid;2,2,2-trifluoroacetic acid |
|---|---|
| PubChem CID | 146054057 |
| Molecular Formula | C25H23ClF3N3O6S |
| Molecular Weight | 585.99 g/mol |
| Exact Mass | 585.09 |
| IUPAC Name | 3-(benzenesulfonamido)-4-[4-(4-chlorophenyl)piperazin-1-yl]benzoic acid;2,2,2-trifluoroacetic acid |
| SMILES | O=C(O)C(F)(F)F.O=C(O)c1ccc(N2CCN(c3ccc(Cl)cc3)CC2)c(NS(=O)(=O)c2ccccc2)c1 |
| InChI | InChI=1S/C23H22ClN3O4S.C2HF3O2/c24-18-7-9-19(10-8-18)26-12-14-27(15-13-26)22-11-6-17(23(28)29)16-21(22)25-32(30,31)20-4-2-1-3-5-20;3-2(4,5)1(6)7/h1-11,16,25H,12-15H2,(H,28,29);(H,6,7) |
| InChIKey | GHWIYJHDZFAZAJ-UHFFFAOYSA-N |
| XLogP | 4.80 |
| TPSA | 127.25 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 585.99 |
| LogP ≤ 5 | 4.80 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146054057 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.